In reaction to strong earnings/guidance: AMZN +20.1% (also upgraded by several analysts), NTGR +13%, (light volume), MKTO +14%, P +10.2%, LOGM +9.9%, QLIK +9.6%, JNPR +9.5%, MITK +7.8%, IG +6.2%, PFPT +5.6%, MXIM +5.4% (also upgraded to Buy from Hold at Evercore ISI ; upgraded to Buy from Neutral at BofA/Merrill), TRN +5.1%, SBUX +5%,(also authorizes the repurchase of an additional 50 million shares of its common stock under its ongoing share repurchase program; Starbucks and PepsiCo entered into agreement for the marketing and sale of SBUX ready-to-drink coffee in Latin America), STS +4.9% (thinly traded), V +4.5% (also Visa believes there is compelling logic for both Visa Inc. and Visa Europe to consummate a business combination), BYD +4%, BLDR +3.9% (light volume), HWAY +3.1%, N +3.1%, LEA +3%, VOD +2.8%, AAL +2.1%, T +2%, SYK +1.8% (light volume), SWKS +1.8%, VFC +1.8% (light volume), ABBV +1.7%, FLEX +1%, RT +0.8%, (light volume), ACTG +0.6%, SAVE +0.5%.
M&A news: SFG +37.5% (StanCorp Fin to be acquired by Meiji Yasuda Life Insurance for $115/share in a $5 bln deal), NOK +2.1% (Nokia receives approval from the European Commission for its pending acquisition of Alcatel-Lucent), DTV +1.7% (FCC releases statement of commissioner Michael O'Rielly on the AT&T (T)/DTV merger application; says ‘process should not have taken this long'), BEE +1.1% (following late move higher on M&A related speculation - Bloomberg indicated co hired advisor to explore sale).
Other news: AMDA +64.8% (signs an original equipment manufacturer letter of intent supply agreement, with a leading orthopedic device design and manufacturing company), ACRX +16.5% (Zalviso (sufentanil), received a positive opinion from the Committee for the treatment of post-operative pain. Hybrid applications rely in part on the results of studies carried out with a reference product and in part on new data), FXCM +5.8% (still checking), UCTT +4.9% (following yesterday's ~30% move higher), JD +3.5% (Nasdaq announced that JD.com (JD) will become a component of the NASDAQ-100 Index and the NASDAQ-100 Equal Weighted Index prior to market open on July 29, 2015), ALU +3.1% (Nokia receives approval from the European Commission for its pending acquisition of Alcatel-Lucent), MA +3% (V sympathy), QRVO +2.7% (following SWKS results), REGN +1.4% (Regeneron Pharms and Sanofi (SNY) receive a positive opinion for the marketing authorization of Praluent, recommending its approval for use in certain adult patients with hypercholesterolemia from the EMA), DEO +1.3% (following late sell-off on potential SEC distribution inquiry), NFLX +1.3% (European pay TV deals under scrutiny), AVGO +0.8% (following SWKS results), TWTR +0.6% (announced plans to introduce event based ad targeting), QCOM +0.4% (Reuters discusses comments from analysts that Intel (INTC) might be a possible suitor for QCOM chip unit), NUE +0.3% (favorable commentary on Thursday's Mad Money).
Analyst comments: BCC +4.3% (upgraded to Buy from Neutral at DA Davidson), SCTY +2.1% (upgraded to Outperform at Robert W. Baird), GOLD +1.4% (upgraded to Buy at Citigroup), UA +1.1% (upgraded to Sector Weight from Underweight at KeyBanc Capital Mkts), UN +1.1% (upgraded to Buy at Canaccord Genuity), UAL +0.9% (upgraded to Buy at Deutsche Bank), DIS +0.5% (upgraded to Buy at Topeka), GM +0.3% (upgraded to Neutral from Underperform at Credit Suisse; also mentioned positively at Citigroup -- discusses several reasons to buy)